What is the recommended treatment and secondary prophylaxis regimen for rheumatic fever?

Rheumatic Fever: Treatment and Secondary Prophylaxis

Acute Treatment

When acute rheumatic fever is diagnosed, immediately administer a full therapeutic course of penicillin to eradicate residual group A Streptococcus, even if throat culture is negative, followed by initiation of long-term secondary prophylaxis. 1

• Begin with benzathine penicillin G 1.2 million units intramuscularly as a single dose for acute eradication 1
• Treat streptococcal infections promptly in family members of patients with rheumatic fever 1
• Provide symptomatic relief with acetaminophen or NSAIDs for moderate to severe symptoms or high fever 2
• Avoid aspirin in children due to Reye's syndrome risk 2

Secondary Prophylaxis Regimens

Benzathine penicillin G 1.2 million units intramuscularly every 4 weeks is the gold-standard prophylaxis and is approximately 10 times more effective than oral antibiotics in preventing recurrence. 1, 3, 2, 4

First-Line Regimen

• Benzathine penicillin G 1.2 million units IM every 4 weeks 1
• For high-risk patients (prior recurrence despite adherence, ongoing high streptococcal exposure, or severe valvular disease), shorten the interval to every 3 weeks to maintain more consistent protective penicillin levels 1, 3

Alternative Regimens for Penicillin Allergy

• Second-line: Penicillin V 250 mg orally twice daily 1
• Third-line: Sulfadiazine 1 g orally once daily (0.5 g for patients ≤27 kg) 1
• Last resort: Macrolide or azalide antibiotics only when allergic to both penicillin and sulfadiazine 1
• Avoid macrolides in patients taking cytochrome P450 3A inhibitors (azole antifungals, HIV protease inhibitors, certain SSRIs) 1

Duration of Secondary Prophylaxis

The duration depends on the presence and severity of cardiac involvement, with longer prophylaxis required for those with residual valvular disease. 1

Clinical Scenario	Duration (whichever is longer)
Rheumatic fever with carditis AND residual valvular disease	10 years after last attack OR until age 40 [1]
Rheumatic fever with carditis but NO residual valvular disease	10 years after last attack OR until age 21 [1]
Rheumatic fever without carditis	5 years after last attack OR until age 21 [1]

Special Considerations for Extended Prophylaxis

• Consider lifelong prophylaxis for patients at high risk of group A Streptococcus exposure, including teachers, daycare workers, healthcare workers in endemic areas, parents of young children, military recruits, and those in crowded living situations 1, 5
• Continue prophylaxis even after valve replacement surgery, as surgery does not eliminate the risk of recurrent acute rheumatic fever 1, 5

Management of Cardiac Complications

When left ventricular systolic dysfunction develops, apply standard guideline-directed medical therapy while continuing secondary prophylaxis. 1, 2, 5

• Initiate diuretics for volume overload 2, 5
• Add ACE inhibitors or ARBs for afterload reduction 1, 2, 5
• Use beta-blockers for heart rate control, especially critical in mitral stenosis where diastolic filling time matters 2, 5
• Consider aldosterone antagonists and sacubitril/valsartan per heart failure guidelines 1, 2, 5
• Add digoxin for additional rate control in atrial fibrillation when beta-blockers alone are insufficient 5
• Avoid abrupt blood pressure lowering in stenotic valve lesions (mitral or aortic stenosis), as this can precipitate hemodynamic collapse 1, 2, 5

Anticoagulation

Anticoagulation should be considered for all patients with rheumatic heart disease who develop atrial fibrillation. 5

• Also reasonable in sinus rhythm patients with very severe left atrial dilatation, spontaneous echo contrast, or concurrent heart failure 5
• Choice between warfarin and direct oral anticoagulants should be individualized based on bleeding versus thromboembolic risk 5

Surgical Intervention

All patients with symptomatic severe rheumatic mitral stenosis should be evaluated for percutaneous mitral balloon commissurotomy (PMBC) or mitral valve surgery within 3 months of diagnosis. 2, 5

• In asymptomatic patients with severe mitral stenosis (valve area ≤1.5 cm²), PMBC at a comprehensive valve center is reasonable 5
• Women with moderate-to-severe mitral stenosis planning pregnancy should undergo PMBC before conception if symptomatic 5
• If percutaneous intervention is required during pregnancy, perform PMBC only after 20 weeks gestation in experienced centers with multidisciplinary teams 5

Infective Endocarditis Prophylaxis

Routine endocarditis prophylaxis is NOT recommended for rheumatic heart disease alone. 1, 3, 2, 5

Antibiotic prophylaxis before dental procedures (gingival manipulation, periapical manipulation, or oral mucosa perforation) is ONLY indicated for:

• Prosthetic cardiac valves (including transcatheter-implanted prostheses and homografts) 1, 2, 5
• Prosthetic material used for valve repair (annuloplasty rings, chords, clips) 1, 2, 5
• Previous infective endocarditis 1, 2, 5
• Unrepaired cyanotic congenital heart disease or repaired disease with residual shunts 1

Important Caveats

• Antibiotic prophylaxis is NOT recommended for non-dental procedures (TEE, esophagogastroduodenoscopy, colonoscopy, cystoscopy) in the absence of active infection 1, 5
• When a patient receiving benzathine penicillin G for rheumatic fever prophylaxis requires dental-procedure endocarditis prophylaxis, use an alternative antibiotic (e.g., amoxicillin or clindamycin) to provide broader coverage 5, 6
• Maintaining optimal oral hygiene remains the single most important preventive measure against infective endocarditis in all patients with rheumatic heart disease 1, 3, 2, 5

Additional Preventive Measures

• Administer influenza and pneumococcal vaccinations according to standard adult vaccination schedules 1, 2, 5
• Encourage regular aerobic exercise to improve cardiovascular fitness in patients with asymptomatic valvular heart disease 1, 2, 5

Critical Pitfalls to Avoid

Never discontinue secondary prophylaxis prematurely, even if the patient feels well, has a normal echocardiogram, or has undergone valve surgery. 3, 5

• Do not stop prophylaxis at arbitrary age cutoffs without evaluating individual risk factors: ongoing streptococcal exposure, severity of valvular disease, time since last attack, and occupational risk 3, 5
• Recurrent rheumatic fever is associated with worsening rheumatic heart disease 1
• Group A Streptococcus infection does not have to be symptomatic to trigger recurrence 1
• Rheumatic fever can recur even when symptomatic infection is treated optimally, which is why continuous prophylaxis rather than episodic treatment is essential 1

Evidence Quality and Context

The evidence supporting intramuscular benzathine penicillin G comes primarily from studies conducted in the 1950s-1960s, but a 2024 Cochrane review confirms moderate-certainty evidence that antibiotics reduce rheumatic fever recurrence (0.7% vs 1.7% without antibiotics) and that intramuscular penicillin is approximately 10-fold more effective than oral antibiotics 4. The greatest benefit is seen in people with early or mild RHD (8.1% recurrence without antibiotics vs 0.7% with prophylaxis) 4. Despite the age of the original studies, the consistency of findings and biological plausibility support current guideline recommendations from the American Heart Association and American College of Cardiology 1, 3, 2, 5.